Antibiotic Resistance Remains Prevalent in Ocular Staphylococcal Infections

Newest ARMOR study data helps inform clinicians when choosing a therapy to pursue in affected patients.

Managing Pediatric Ocular Pathology

Safe treatment of these patients requires a comprehensive understanding of available therapeutics.

Update your Glaucoma Prescribing Protocols

Treatment options continue to evolve, with new meds and methods to consider.

Hearing Loss a Possible Complication of Thyroid Eye Disease Drug

A small case series of teprotumumab-treated patients experienced auditory changes and other otologic symptoms.

Teprotumumab Promising as Treatment For Proptosis, Diplopia

Compared with placebo and methylprednisolone, the drug was associated with greater symptomatic improvement.

Oral CAIs More Safe Than Many Believe

The risk of adverse events was comparable to that of topical formulations, study finds.

First Presbyopia Eye Drop Approved

The pilocarpine agent improves near and intermediate acuity, according to manufacturer Allergan.

TNS Safe Treatment for Ocular Pain

Study suggests three- to six-month use of a trigeminal neurostimulator decreased eye pain, light and wind sensitivity, and burning sensations.

Stay Alert for Systemic Med Surprises

Many ocular adverse effects may be hiding inside your patient’s pill bottle. Here’s a new way to think about them.

Managing Miotics and Mydriatics

Take a closer look at old, new and future uses of these drugs.

Upcoming Events

May 24, 2022

Early Identification and Timely Referral
Location: Virtual Event
Speakers: Carolyn Majcher, OD, FAAO, FORS, and Jonathan Jonisch, MD
7:00–8:00pm EST

Sponsored by Regeneron

Register here

June 10-11, 2022

Intrepid Presents: Innovations and Implementations in Practice
Location: Renaissance Newport Beach
Program Co-chairs: Nathan Lighthizer, OD, FAAO and John D. Gelles, OD, FIAO, FCLSA
Earn 14 LIVE COPE Credits (approval pending)

Register here

June 16, 2022

Establishing a Partnership in the Effective Management of Patients with Diabetic Retinal Disease
Location: The Palm Chicago
Speakers: Steven Ferrucci, OD, FAAO, and Dilsher Dhoot, MD
7:30–8:30pm CST

Sponsored by Regeneron

Register here